Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103326322 | 10332632 | 2 | F | 20160713 | 20140722 | 20160715 | EXP | TR-BRISTOL-MYERS SQUIBB COMPANY-21204250 | BRISTOL MYERS SQUIBB | 31.00 | YR | F | Y | 0.00000 | 20160715 | OT | TR | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103326322 | 10332632 | 1 | PS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Oral | 14 TABS | Y | 21436 | 5 | MG | TABLET | ||||||
| 103326322 | 10332632 | 2 | I | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 20 TABS | Y | 0 | 10 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103326322 | 10332632 | 1 | Depression |
| 103326322 | 10332632 | 2 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103326322 | 10332632 | OT |
| 103326322 | 10332632 | LT |
| 103326322 | 10332632 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103326322 | 10332632 | Anal incontinence | |
| 103326322 | 10332632 | Drug interaction | |
| 103326322 | 10332632 | Overdose | |
| 103326322 | 10332632 | Suicide attempt | |
| 103326322 | 10332632 | Urinary incontinence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |